Stefan Larsson
Ask VT AI
View News Summary
- U.S. tariff hike on Taiwan rattles global markets, drawing widespread criticism for inconsistency.
- Regeneron beats Q2 earnings estimates on strong Dupixent sales, despite challenges with Eylea and regulatory delays.
- Trump administration plans pilot program to cover expensive obesity drugs in Medicaid and Medicare, highlighting concerns over long-term affordability and need for lifestyle coaching.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- U.S. tariff hike on Taiwan rattles global markets, drawing widespread criticism for inconsistency.
- Regeneron beats Q2 earnings estimates on strong Dupixent sales, despite challenges with Eylea and regulatory delays.
- Trump administration plans pilot program to cover expensive obesity drugs in Medicaid and Medicare, highlighting concerns over long-term affordability and need for lifestyle coaching.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Stefan Larsson
News from Stefan Larsson